These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12719580)

  • 101. Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set.
    Dhillon AK; Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA
    Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):792-802. PubMed ID: 18566514
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.
    Klein F; Diskin R; Scheid JF; Gaebler C; Mouquet H; Georgiev IS; Pancera M; Zhou T; Incesu RB; Fu BZ; Gnanapragasam PN; Oliveira TY; Seaman MS; Kwong PD; Bjorkman PJ; Nussenzweig MC
    Cell; 2013 Mar; 153(1):126-38. PubMed ID: 23540694
    [TBL] [Abstract][Full Text] [Related]  

  • 103. De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics.
    Zhao G; Richaud AD; Williamson RT; Feig M; Roche SP
    ACS Chem Biol; 2024 Jul; 19(7):1583-1592. PubMed ID: 38916527
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.
    Chu TH; Crowley AR; Backes I; Chang C; Tay M; Broge T; Tuyishime M; Ferrari G; Seaman MS; Richardson SI; Tomaras GD; Alter G; Leib D; Ackerman ME
    PLoS Pathog; 2020 Feb; 16(2):e1008083. PubMed ID: 32092122
    [TBL] [Abstract][Full Text] [Related]  

  • 105. An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries.
    Petersen BM; Kirby MB; Chrispens KM; Irvin OM; Strawn IK; Haas CM; Walker AM; Baumer ZT; Ulmer SA; Ayala E; Rhodes ER; Guthmiller JJ; Steiner PJ; Whitehead TA
    Nat Commun; 2024 May; 15(1):3974. PubMed ID: 38730230
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.
    Abdel-Motal UM; Sarkis PT; Han T; Pudney J; Anderson DJ; Zhu Q; Marasco WA
    PLoS One; 2011; 6(10):e26473. PubMed ID: 22031835
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Bos taurus ultralong CDR H3 antibodies.
    Vadnais ML; Smider VV
    Curr Opin Struct Biol; 2016 Jun; 38():62-7. PubMed ID: 27295423
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains.
    Wang S; Chan KW; Wei D; Ma X; Liu S; Hu G; Park S; Pan R; Gu Y; Nazzari AF; Olia AS; Xu K; Lin BC; Louder MK; Doria-Rose NA; Montefiori D; Seaman MS; Zhou T; Kwong PD; Arthos J; Kong XP; Lu S
    Res Sq; 2023 Oct; ():. PubMed ID: 37886518
    [TBL] [Abstract][Full Text] [Related]  

  • 109. An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries.
    Petersen BM; Kirby MB; Chrispens KM; Irvin OM; Strawn IK; Haas CM; Walker AM; Baumer ZT; Ulmer SA; Ayala E; Rhodes ER; Guthmiller JJ; Steiner PJ; Whitehead TA
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293170
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.
    McLellan JS; Pancera M; Carrico C; Gorman J; Julien JP; Khayat R; Louder R; Pejchal R; Sastry M; Dai K; O'Dell S; Patel N; Shahzad-ul-Hussan S; Yang Y; Zhang B; Zhou T; Zhu J; Boyington JC; Chuang GY; Diwanji D; Georgiev I; Kwon YD; Lee D; Louder MK; Moquin S; Schmidt SD; Yang ZY; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Burton DR; Koff WC; Walker LM; Phogat S; Wyatt R; Orwenyo J; Wang LX; Arthos J; Bewley CA; Mascola JR; Nabel GJ; Schief WR; Ward AB; Wilson IA; Kwong PD
    Nature; 2011 Nov; 480(7377):336-43. PubMed ID: 22113616
    [TBL] [Abstract][Full Text] [Related]  

  • 111. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
    Joshi VR; Claiborne DT; Pack ML; Power KA; Newman RM; Batorsky R; Bean DJ; Goroff MS; Lingwood D; Seaman MS; Rosenberg E; Allen TM
    J Virol; 2024 Mar; 98(3):e0172023. PubMed ID: 38412036
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Broadly neutralizing antibodies targeting HIV: Progress and challenges.
    Paneerselvam N; Khan A; Lawson BR
    Clin Immunol; 2023 Dec; 257():109809. PubMed ID: 37852345
    [TBL] [Abstract][Full Text] [Related]  

  • 113. IgG1-b12-HIV-gp120 Interface in Solution: A Computational Study.
    Martí D; Alemán C; Ainsley J; Ahumada O; Torras J
    J Chem Inf Model; 2022 Jan; 62(2):359-371. PubMed ID: 34971312
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target.
    Parker Miller E; Finkelstein MT; Erdman MC; Seth PC; Fera D
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578355
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.
    Chang HW; Frey G; Liu H; Xing C; Steinman L; Boyle WJ; Short JM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33627407
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold.
    Koksal AC; Pennini ME; Marelli M; Xiao X; Dall'Acqua WF
    MAbs; 2019; 11(4):725-734. PubMed ID: 30900513
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding.
    Watanabe Y; Vasiljevic S; Allen JD; Seabright GE; Duyvesteyn HME; Doores KJ; Crispin M; Struwe WB
    Anal Chem; 2018 Jun; 90(12):7325-7331. PubMed ID: 29757629
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
    Easterhoff D; Moody MA; Fera D; Cheng H; Ackerman M; Wiehe K; Saunders KO; Pollara J; Vandergrift N; Parks R; Kim J; Michael NL; O'Connell RJ; Excler JL; Robb ML; Vasan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Nitayaphan S; Sinangil F; Tartaglia J; Phogat S; Kepler TB; Alam SM; Liao HX; Ferrari G; Seaman MS; Montefiori DC; Tomaras GD; Harrison SC; Haynes BF
    PLoS Pathog; 2017 Feb; 13(2):e1006182. PubMed ID: 28235027
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.
    Li X; Grant OC; Ito K; Wallace A; Wang S; Zhao P; Wells L; Lu S; Woods RJ; Sharp JS
    Biochemistry; 2017 Feb; 56(7):957-970. PubMed ID: 28102671
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.